Besides, reduced Farnesoid X (FXR) receptor signaling during hepatic inflammation induces to decrease in bile acid transporter proteins, resulting in elevated bile acids and persistent hepatic inflammation, which promote the development of HCC (40, 41). Here, NR1H4 is linked to hepatocellular carcinoma.